643 related articles for article (PubMed ID: 29785080)
1. Prognostic impact of the red cell distribution width in esophageal cancer patients: A systematic review and meta-analysis.
Xu WY; Yang XB; Wang WQ; Bai Y; Long JY; Lin JZ; Xiong JP; Zheng YC; He XD; Zhao HT; Sang XT
World J Gastroenterol; 2018 May; 24(19):2120-2129. PubMed ID: 29785080
[TBL] [Abstract][Full Text] [Related]
2. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy.
Ji WH; Jiang YH; Ji YL; Li B; Mao WM
Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of hematological parameters in patients undergoing esophagectomy for esophageal squamous cell carcinoma.
Hirahara N; Matsubara T; Kawahara D; Mizota Y; Ishibashi S; Tajima Y
Int J Clin Oncol; 2016 Oct; 21(5):909-919. PubMed ID: 27154178
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of red cell distribution width in esophageal squamous cell carcinoma.
Hirahara N; Tajima Y; Fujii Y; Hyakudomi R; Yamamoto T; Ishitobi K; Taniura T; Kawabata Y
J Surg Res; 2018 Oct; 230():53-60. PubMed ID: 30100040
[TBL] [Abstract][Full Text] [Related]
5. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
[TBL] [Abstract][Full Text] [Related]
6. Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma.
Tian R; Yan H; Zhang F; Sun P; Wu AR; Zhang M; Jiang YL; Wu J; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
Oncotarget; 2016 Sep; 7(38):61533-61543. PubMed ID: 27517497
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of RDW in cancers: a systematic review and meta-analysis.
Hu L; Li M; Ding Y; Pu L; Liu J; Xie J; Cabanero M; Li J; Xiang R; Xiong S
Oncotarget; 2017 Feb; 8(9):16027-16035. PubMed ID: 27926498
[TBL] [Abstract][Full Text] [Related]
8. The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China.
Sun P; Zhang F; Chen C; Bi X; Yang H; An X; Wang F; Jiang W
Oncotarget; 2016 Jul; 7(27):42650-42660. PubMed ID: 27223088
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and survival values of neutrophil-lymphocyte ratio (NLR) and red blood cell distribution width (RDW) in esophageal cancer.
Han F; Liu Y; Cheng S; Sun Z; Sheng C; Sun X; Shang X; Tian W; Wang X; Li J; Liu D; Wang Y; Zhang B; Ju Y
Clin Chim Acta; 2019 Jan; 488():150-158. PubMed ID: 30389457
[TBL] [Abstract][Full Text] [Related]
10. A Nomogram to Predict Prognostic Value of Red Cell Distribution Width in Patients with Esophageal Cancer.
Chen GP; Huang Y; Yang X; Feng JF
Mediators Inflamm; 2015; 2015():854670. PubMed ID: 26578822
[TBL] [Abstract][Full Text] [Related]
11. Elevated red cell distribution width contributes to a poor prognosis in patients with esophageal carcinoma.
Wan GX; Chen P; Cai XJ; Li LJ; Yu XJ; Pan DF; Wang XH; Wang XB; Cao FJ
Clin Chim Acta; 2016 Jan; 452():199-203. PubMed ID: 26633854
[TBL] [Abstract][Full Text] [Related]
12. The value of cellular components of blood in the setting of trimodal therapy for esophageal cancer.
Tustumi F; Takeda FR; Viyuela MS; da Cruz Junior JB; Brandão AAGS; Sallum RAA; Ribeiro Junior U; Cecconello I
J Surg Oncol; 2020 Apr; 121(5):784-794. PubMed ID: 31762058
[TBL] [Abstract][Full Text] [Related]
13. Preoperative sarcopenia is a predictor of poor prognosis of esophageal cancer after esophagectomy: a comprehensive systematic review and meta-analysis.
Deng HY; Zha P; Peng L; Hou L; Huang KL; Li XY
Dis Esophagus; 2019 Mar; 32(3):. PubMed ID: 30496385
[TBL] [Abstract][Full Text] [Related]
14. Cumulative prognostic scores based on plasma fibrinogen and serum albumin levels in esophageal cancer patients treated with transthoracic esophagectomy: comparison with the Glasgow prognostic score.
Matsuda S; Takeuchi H; Kawakubo H; Fukuda K; Nakamura R; Takahashi T; Wada N; Saikawa Y; Omori T; Kitagawa Y
Ann Surg Oncol; 2015 Jan; 22(1):302-10. PubMed ID: 24952029
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of plasma fibrinogen level as a predictive marker for postoperative recurrence of esophageal squamous cell carcinoma in patients receiving neoadjuvant treatment.
Matsuda S; Takeuchi H; Fukuda K; Nakamura R; Takahashi T; Wada N; Kawakubo H; Saikawa Y; Omori T; Kitagawa Y
Dis Esophagus; 2014; 27(7):654-61. PubMed ID: 23980622
[TBL] [Abstract][Full Text] [Related]
16. Extracapsular lymph node involvement is a robust survival predictor in esophageal cancer patients: A pooled analysis.
Chen D; Mao Y; Zheng Y; Wen J; Song P; Xue Y; Wang W; Sang Y; Chen Y; Dai C
Eur J Surg Oncol; 2021 Aug; 47(8):1875-1882. PubMed ID: 33795171
[TBL] [Abstract][Full Text] [Related]
17. Preoperative serum fibrinogen is an independent prognostic factor in operable esophageal cancer.
Zhang SS; Lei YY; Cai XL; Yang H; Xia X; Luo KJ; Su CH; Zou JY; Zeng B; Hu Y; Luo HH
Oncotarget; 2016 May; 7(18):25461-9. PubMed ID: 27009857
[TBL] [Abstract][Full Text] [Related]
18. C-Met as a potential novel prognostic marker in squamous cell carcinoma and adenocarcinoma of esophagus: evidence from a meta-analysis.
Ren JL; Wu HF; Wang WJ; Hu GM; Gu B; Zhang M; Wang YX
Panminerva Med; 2017 Mar; 59(1):97-106. PubMed ID: 27636117
[TBL] [Abstract][Full Text] [Related]
19. Lymph node harvest in esophageal cancer after neoadjuvant chemoradiotherapy.
Shridhar R; Hoffe SE; Almhanna K; Weber JM; Chuong MD; Karl RC; Meredith K
Ann Surg Oncol; 2013 Sep; 20(9):3038-43. PubMed ID: 23625142
[TBL] [Abstract][Full Text] [Related]
20. Prognostic histological factors in patients with esophageal squamous cell carcinoma after preoperative chemoradiation followed by surgery.
Tu CC; Hsu PK; Chien LI; Liu WC; Huang CS; Hsieh CC; Hsu HS; Wu YC
BMC Cancer; 2017 Jan; 17(1):62. PubMed ID: 28103913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
